tbuckley/cabot-search huggingface dataset:
Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
Authors: Xing Chang, Amanda Lochner, Hsueh-Hsiao Wang, Shuyi Wang, Hang Zhu, Jun Ren, Hao Zhou
Journal: Theranostics (2021)

Endothelial cells (ECs) constitute the innermost layer in all blood vessels to maintain the structural integrity and microcirculation function for coronary microvasculature. Impaired endothelial function is demonstrated in various cardiovascular diseases including myocardial infarction (MI), which is featured by reduced myocardial blood flow as a result of epicardial coronary obstruction, thrombogenesis, and inflammation. In this context, understanding the cellular and molecular mechanisms governing the function of coronary ECs is essential for the early diagnosis and optimal treatment of MI. Although ECs contain relatively fewer mitochondria compared with cardiomyocytes, they function as key sensors of environmental and cellular stress, in the regulation of EC viability, structural integrity and function. Mitochondrial quality control (MQC) machineries respond to a broad array of stress stimuli to regulate fission, fusion, mitophagy and biogenesis in mitochondria. Impaired MQC is a cardinal feature of EC injury and dysfunction. Hence, medications modulating MQC mechanisms are considered as promising novel therapeutic options in MI. Here in this review, we provide updated insights into the key role of MQC mechanisms in coronary ECs and microvascular dysfunction in MI. We also discussed the option of MQC as a novel therapeutic target to delay, reverse or repair coronary microvascular damage in MI. Contemporary available MQC-targeted therapies with potential clinical benefits to alleviate coronary microvascular injury during MI are also summarized.
PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI
Authors: Matteo Nardin, Davide Cao, Mauro Chiarito, Johny Nicolas, Samantha Sartori, Zhongjie Zhang, Hanbo Qiu, Ali Turfah, Gennaro Giustino, Rishi Chandiramani, Ridhima Goel, Anastasios Roumeliotis, Giulio Stefanini, Prakash Krishnan, Nitin Barman, Joseph Sweeny, Usman Baber, George Dangas, Roxana Mehran, Samin Sharma, Annapoorna Kini
Journal: Journal of the American College of Cardiology (2021)
DEEP LEARNING ENABLED ELECTROCARDIOGRAPHIC PREDICTION OF COMPUTER TOMOGRAPHY-BASED HIGH CORONARY CALCIUM SCORE (CAC)
Authors: Jose Medina-Inojosa, Michal Shelly, Zachi Itzhak Attia, Peter Noseworthy, Paul Friedman, Rickey Carter, Francisco Lopez-Jimenez
Journal: Journal of the American College of Cardiology (2021)
NOVEL USE OF AN IRRIGATION ABLATION CATHETER TO MONITOR REAL TIME HEMODYNAMICS DURING ABLATION
Authors: Neal K. Bhatia, Rachel Slappy, Soroosh Kiani, Stacy Westerman, Mikhael El-Chami, David DeLurgio, Faisal Merchant, Anshul Patel, Michael Lloyd, Anand Shah
Journal: Journal of the American College of Cardiology (2021)
Abstract 14284: Detyrosinated Tubulin as Treatment Target in Genetic Heart Disease: Proteomic and Functional Studies in Hypertrophic Cardiomyopathy
Authors: Maike Schuldt, Jiayi Pei, Magdalena Harakalova, Larissa M Dorsch, Michal Mokry, Jaco C Knol, Tang V Pham, Tim Schelfhorst, Sander R Piersma, Cris G Dos Remedios, Michiel Dalinghaus, Michelle Michels, Folkert W Asselbergs, Connie R Jimenez, Jolanda van der Velden, Diederik W Kuster
Journal: Circulation (2019)

Introduction: Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease. Mutations in genes encoding sarcomere proteins are the most common cause (sarcomere mutation positive: SMP)...
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Authors: Julia Stomper, John Charles Rotondo, Gabriele Greve, Michael Lübbert
Journal: Leukemia (2021)

Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA methylation, thereby triggering the re-programming of tumor cells. The first-generation HMA azacitidine and decitabine have now been in standard clinical use for some time, offering a valuable alternative to previous treatments in acute myeloid leukemia and myelodysplastic syndromes, so far particularly in older, medically non-fit patients. However, the longer we use these drugs, the more we are confronted with the (almost inevitable) development of resistance. This review provides insights into the mode of action of HMA, mechanisms of resistance to this treatment, and strategies to overcome HMA resistance including next-generation HMA and HMA-based combination therapies.
연구논문 : 4 cm 이하의 단일결절 간세포암종에서 고주파열치료와 경동맥화학색전술의 효과 비교
Authors: Yang Min Jae, 안소연, Eun Joon Moon, 이민석, 황주안, 정재연, Je Hwan Won, 김재근, Wang Hee Jung, Sung Won Cho
Journal: Clinical and Molecular Hepatology (2009)

목적: 간세포암종에서 경동맥화학색전술과 고주파열치료의 효과를 비교한 연구는 드물다. 저자들은 단일결절 간세포암종을 진단받고, 고주파열치료 혹은 경동맥화학색전술 시행 후 완전반응을 보인 환자들에서 치료법에 따른 재발 및 생존율의 차이를 비교하고, 이에 관여하는 예후인자들을 분석하고자 하였다. 대상과 방법: 2002년 1월부터 2009년 2월까지 간외 전이와 혈관 침범이 없는, 4 cm 이하의 단일결절 간세포암종을 진단받고 일차 치료로서 고주파열치료 혹은 경동맥화학색전술을 시행받았던 환자군 중에서, 시술 후 전산화단층촬영상 완전괴사나 완전 리피오돌 흡착 반응을 보이고 1년 이상 추적관찰이 확인된 43명의 고주파열치료 환자와 50명의 경동맥화학색전술 환자를 선별하였다. 결과: 1년, 2년, 3년 누적재발률은 고주파열치료군에서 각각 33.9%, 44.3%, 55.4%였고, 경동맥화 학색전술군에서 각각 42%, 68.3%, 71.7%로 고주파 열치료군에서 낮았으나, 통계적인 유의성은 없었다(P=0.130, log-rank test). 1년, 2년, 3년 누적생존율은 고주파열치료군에서 각각 97.7%, 77.4%, 63.1%, 경동맥화학색전술군에서 각각 95.9%, 76.1%, 60.2%로 두 군이 유사하였다(P=0.495). 다변량 분석 결과 남성, B형간염, 높은 알부민 수치를 보이는 환자들에서 통계적으로 유의하게 생존율이 높았다. 결론: 4 cm 이하의 단일결절 간세포암종 환자에서 경동맥화학색전술 또는 고주파열치료를 시행한 후, 완전반응을 보인 환자들을 대상으로 3년간 추적관찰한 결과, 두 치료군 간에 재발률 및 생존율의 차이가 없었다. 향후, 장기 예후의 차이를 알아보기 위한 연구가 필요하다.
SOCIOECONOMIC STATUS AND ITS IMPACT ON OUTCOMES AFTER SURGICAL VS TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Alexis K. Okoh, Xiaoyan Deng, Fady Soliman, Kush Patel, John Kassotis, Bruce Haik, Ashok Chaudhary, Leonard Lee, Chunguang Chen, Mark Russo
Journal: Journal of the American College of Cardiology (2021)
IGG4 RELATED DISEASE: A RARE CAUSE OF RECURRENT PERICARDIAL EFFUSION AND CONSTRICTIVE PERICARDITIS
Authors: Abhishek Bose, Yash Jobanputra, Internal Avinashsingh Eswarsingh, Parag Anilkumar Chevli, Neeta Shah
Journal: Journal of the American College of Cardiology (2021)
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
Authors: Uriel Trahtemberg, Robert Rottapel, Claudia C Dos Santos, Arthur S Slutsky, Andrew Baker, Marvin J Fritzler
Journal: Annals of the Rheumatic Diseases (2021)

Reports of severe COVID-19 being associated with thrombosis, antiphospholipid antibodies (APLA), and antiphospholipid syndrome have yielded disparate conclusions. Studies comparing patients with COVID-19 with contemporaneous controls of similar severity are lacking.
ONE-YEAR OUTCOMES WITH INTRAVASCULAR ULTRASOUND GUIDANCE IN PERCUTANEOUS CORONARY INTERVENTION
Authors: Zachary Zuzek, Shilpkumar Arora, Rahul Jaswaney, Chinmay Jani, Irfan Helmy, Kirtenkumar Patel, Mohammed Osman, Guilherme Attizzani
Journal: Journal of the American College of Cardiology (2021)
COMPARISON OF ANTI-FACTOR XA ACTIVITY VALUES ON EDOXABAN THERAPY IN RELATION TO BASELINE RENAL FUNCTION IN PATIENTS WITHATRIAL FIBRILLATION
Authors: Ryohei Ono, Kenichi Fukushima, Hidehisa Takahashi, Yasuhiko Hori, Yoshio Kobayashi
Journal: Journal of the American College of Cardiology (2021)
IS BRADYCARDIA A PROGNOSTIC INDICATOR OF COVID-19 MORTALITY? A SINGLE CENTER RETROSPECTIVE COHORT ANALYSIS
Authors: Iyad Farouji, Kok Hoe Chan, Ahmad Damati, Chrystina Kiwan, Arwa Battah, Safia Afaq, Hossam Abed, Mirette Habib, Jihad Slim
Journal: Journal of the American College of Cardiology (2021)
Mn-containing bioceramics inhibit osteoclastogenesis and promote osteoporotic bone regeneration via scavenging ROS
Authors: Jianmei Li, Cuijun Deng, Wanyuan Liang, Fei Kang, Yun Bai, Bing Ma, Chengtie Wu, Shiwu Dong
Journal: Bioactive Materials (2021)

Osteoporosis is caused by an osteoclast activation mechanism. People suffering from osteoporosis are prone to bone defects. Increasing evidence indicates that scavenging reactive oxygen species (ROS) can inhibit receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclastogenesis and suppress ovariectomy-induced osteoporosis. It is critical to develop biomaterials with antioxidant properties to modulate osteoclast activity for treating osteoporotic bone defects. Previous studies have shown that manganese (Mn) can improve bone regeneration, and Mn supplementation may treat osteoporosis. However, the effect of Mn on osteoclasts and the role of Mn in osteoporotic bone defects remain unclear. In present research, a model bioceramic, Mn-contained β-tricalcium phosphate (Mn-TCP) was prepared by introducing Mn into β-TCP. The introduction of Mn into β-TCP significantly improved the scavenging of oxygen radicals and nitrogen radicals, demonstrating that Mn-TCP bioceramics might have antioxidant properties. The in vitro and in vivo findings revealed that Mn2+ ions released from Mn-TCP bioceramics could distinctly inhibit the formation and function of osteoclasts, promote the differentiation of osteoblasts, and accelerate bone regeneration under osteoporotic conditions in vivo. Mechanistically, Mn-TCP bioceramics inhibited osteoclastogenesis and promoted the regeneration of osteoporotic bone defects by scavenging ROS via Nrf2 activation. These results suggest that Mn-containing bioceramics with osteoconductivity, ROS scavenging and bone resorption inhibition abilities may be an ideal biomaterial for the treatment of osteoporotic bone defect.
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
Authors: Ganqiang Liu, Jiajie Peng, Zhixiang Liao, Joseph Locascio, Jean-Christophe Corvol, Frank Zhu, Xianjun Dong, Jodi Maple-Grødem, Meghan Campbell, Alexis Elbaz, Suzanne Lesage, Alexis Brice, Graziella Mangone, John Growdon, Albert Hung, Michael Schwarzschild, Michael Hayes, Anne-Marie Wills, Todd Herrington, Bernard Ravina, Ira Shoulson, Pille Taba, Sulev Kõks, Thomas Beach, Florence Cormier-Dequaire, Guido Alves, Ole-Bjørn Tysnes, Joel Perlmutter, Peter Heutink, Sami Amr, Jacobus van Hilten, Jacobus van Hilten, Meike Kasten, Brit Mollenhauer, Claudia Trenkwalder, Christine Klein, Roger Barker, Caroline Williams-Gray, Johan Marinus, Clemens Scherzer
Journal: Nature Genetics (2021)
Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Inhibits Osteoclast Activity and Restores Osteoblast Activity in a Murine Model of Multiple Myeloma Bone Disease
Authors: Josephine Muller, Arnold Bolomsky, Kathrin Schonfelder, Frederic Baron, Yves Beguin, Heinz Ludwig, Jo Caers, Roy Heusschen
Journal: Blood (2017)
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment
Authors: Lindsay B Alcaraz, Aude Mallavialle, Timothée David, Danielle Derocq, Frédéric Delolme, Cindy Dieryckx, Caroline Mollevi, Florence Boissière-Michot, Joëlle Simony-Lafontaine, Stanislas Du Manoir, Pitter F. Huesgen, Christopher M. Overall, Sophie Tartare-Deckert, William Jacot, Thierry Chardès, Séverine Guiu, Pascal Roger, Thomas Reinheckel, Catherine Moali, Emmanuelle Liaudet-Coopman
Journal: Theranostics (2021)

à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Diagnostic performance of high‐throughput sequencing of the T‐cell receptor beta gene for the diagnosis of cutaneous T‐cell lymphoma
Authors: C. Zimmermann, M. Boisson, C. Ram‐Wolff, A. Sadoux, B. Louveau, M.‐D. Vignon‐Pennamen, J. Rivet, J.‐M. Cayuela, G. Dobos, H. Moins‐Teisserenc, M. Roelens, A. Gruber, C. Lebbé, M. Bagot, M. Battistella, S. Mourah, A. Masson
Journal: British Journal of Dermatology (2021)
PROGNOSIS AFTER DEFERRAL OF REVASCULARIZATION FOR INTERMEDIATE CORONARY STENOSIS WITH ABNORMAL FRACTIONAL FLOW RESERVE AND PRESERVED CORONARY FLOW RESERVE
Authors: Doosup Shin, Joo Myung Lee, Seung Hun Lee, Doyeon Hwamg, Ki Hong Choi, Hyun Kuk Kim, Joon-Hyung Doh, Chang-Wook Nam, Eun-Seok Shin, Masahiro Hoshino, Tadashi Murai, Hernan Mejia-Renteria, Tsunekazu Kakuta, Javier Escaned, Bon-Kwon Koo
Journal: Journal of the American College of Cardiology (2021)
DETERMINANTS OF POOR HEALTH RELATED QUALITY OF LIFE ASSESSMENT AMONG PATIENTS WITH HEART FAILURE
Authors: Tuoyo O. Mene-Afejuku, Abayomi O. Bamgboje, Shushan Veranyan, Ela-Anamaria Moisa, Hansang Park, Monil Majmundar, Savi Mushiyev, Ferdinand Visco, Gerald Pekler
Journal: Journal of the American College of Cardiology (2021)
ANTIHYPERTENSIVE MONOTHERAPY: AMLODIPINE VS. CHLORTHALIDONE IN SPRINT
Authors: Deep Vakil, Stavros Zinonos, John B. Kostis, Jeanne M. Dobrzynski, Nora M. Cosgrove, Abel E. Moreyra, William J. Kostis
Journal: Journal of the American College of Cardiology (2021)
SURGICAL CUTDOWN VERSUS PERCUTANEOUS ACCESS IN TRANSFEMORAL TAVR: A CONTEMPORARY MULTI-CENTER EXPERIENCE AND UPDATED META-ANALYSIS
Authors: Saurav Chatterjee, Juan Mauri, Azhar Supariwala, Efstathia Mihelis, Dillon Gurciullo, Christina Brennan, Sridhar Uttara, Luis Gruberg, Puneet Gandotra
Journal: Journal of the American College of Cardiology (2021)
Hyaluronic acid facilitates bone repair effects of calcium phosphate cement by accelerating osteogenic expression
Authors: Xu Cui, Chengcheng Huang, Zhizhen Chen, Meng Zhang, Chunyu Liu, Kun Su, Jianyun Wang, Li Li, Renxian Wang, Bing Li, Dafu Chen, Changshun Ruan, Deping Wang, William W. Lu, Haobo Pan
Journal: Bioactive Materials (2021)

Calcium phosphate cements (CPC) are widely anticipated to be an optimum bone repair substitute due to its satisfied biocompatibility and degradability, suitable to be used in minimally invasive treatment of bone defects. However the clinical application of CPC is still not satisfied by its poor cohesiveness and mechanical properties, in particular its osteoinductivity. Hyaluronic acid reinforced calcium phosphate cements (HA/CPC) showed extroadinary potential not only enhancing the compressive strength of the cements but also significantly increasing its osteoinductivity. In our study, the compressive strength of HA/CPC increased significantly when the cement was added 1% hyaluronic acid (denoted as 1-HA/CPC). In the meantime, hyaluronic acid obviously promoted ALP activity, osteogenic related protein and mRNA expression of hBMSCs (human bone marrow mesenchymal stem cells) in vitro, cement group of HA/CPC with 4% hyaluronic acid adding (denoted as 4-HA/CPC) showed optimal enhancement in hBMSCs differentiation. After being implanted in rat tibial defects, 4-HA/CPC group exhibited better bone repair ability and bone growth promoting factors, comparing to pure CPC and 1-HA/CPC groups. The underlying biological mechanism of this stimulation for HA/CPC may be on account of higher osteogenic promoting factors secretion and osteogenic genes expression with hyaluronic acid incorporation. These results indicate that hyaluronic acid is a highly anticipated additive to improve physicochemical properties and osteoinductivity performance of CPCs for minimally invasive healing of bone defects.
FIRST GLOBAL CASE OF USING 5G-CLOUD TECHNOLOGY SUPPORT PLATFORM FOR ZERO-CONTACT PARAMETER TESTING AND PROGRAMMING DURING IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION
Authors: Lin Tong, Han-Xiong Liu, Cai-Yan Cui, Yu-Mei Zhang, Jin Li, Shu-juan Qin, Yun Tian, Lin Cai
Journal: Journal of the American College of Cardiology (2021)
INTRACORONARY OPTICAL COHERENCE TOMOGRAPHY-DERIVED VIRTUAL FRACTIONAL FLOW RESERVE TO PREDICT POST-PCI OUTCOMES
Authors: Fumiyasu Seike, Eisuke Usui, Mitsuaki Matsumura, Allen Jeremias, Evan Shlofmitz, Ziad Ali, James Nguyen, Craig Porter, Jane Cao, Thomas Pappas, George Petrossian, Jeffrey Moses, Kazunori Yasuda, Gary Mintz, Richard Shlofmitz, Akiko Maehara
Journal: Journal of the American College of Cardiology (2021)
THE ROLE OF SMOKING ON PROGRESSION OF DEGENERATIVE AORTIC ROOT DILATATION
Authors: Internal M. Avinashsingh Eswarsingh, Abhishek Bose, Tareq Islam, Sai Vikram Alampoondi Venkataramanan, Shanil Shah, Anjani Muthyala, Shamitha Alisa Manohar, Shwetha Rupendu, Neeta Shah
Journal: Journal of the American College of Cardiology (2021)
Khalid Yusoff: champion of excellence in Malaysian medical research
Authors: Martin McKee
Journal: BMJ (2021)

Khalid Yusoff, who has died at the age of 66, was a UK trained cardiologist who spent three decades promoting excellence in medical research in Malaysia, occupying leadership positions in three of the country’s leading universities and as a trusted adviser to successive governments.

The oldest of four brothers, Khalid was born in Kelantan, in the north east of the Malaysian peninsula. His father was a judge in the Malaysian Syariah (sharia) Court, which has jurisdiction over Muslims in respect of certain aspects of Islamic law. His mother was a homemaker. His upbringing was not always easy, and he spent much time looking after his three younger brothers. He had, however, an insatiable desire for education, encouraged by some deeply committed teachers, one of whom walked several miles each day to his home, often staying late to work with him by the light of a kerosene lamp. Recognised as an exceptional student even in primary school, he was awarded a series of scholarships that would take him across the globe in the following decade. The first took him to the prestigious Malay College of Kuala Kangsar, sometimes called the “Eton of the east.” The second, in 1973, was one of only 20 awarded each year to Malaysian students to study in Australia, taking him to McKinnon High School in Melbourne. The third, a Colombo Plan scholarship, which supported university education in the Commonwealth, allowed him to join the medical school of …
GUIDELINE RECOMMENDED THERAPIES AND CLINICAL OUTCOMES IN PATIENTS WITH A PARTICULARLY HIGH-RISK FOR RECURRENT CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME
Authors: Tzlil Grinberg, Yoav Hammer, Maya Wiessman, Tal Ovdat, Ran Kornowski, Alon Eisen
Journal: Journal of the American College of Cardiology (2021)
RADIOMICS-BASED PRECISION PHENOTYPING DISTINGUISHES CULPRIT AND NONCULPRIT LESIONS IN MYOCARDIAL INFARCTION AND LESIONS IN STABLE CORONARY ARTERY DISEASE
Authors: Andrew Lin, Márton Kolossváry, Sebastien Cadet, Priscilla McElhinney, Jeremy Yuvaraj, Nitesh Nerlekar, Stephen Nicholls, Piotr Slomka, Pál Maurovich-Horvat, Dennis Wong, Damini Dey
Journal: Journal of the American College of Cardiology (2021)
THE ASSOCIATION OF DIABETES DURATION AND GLYCEMIC CONTROL WITH STROKE IN PATIENTS WITH ATRIAL FIBRILLATION AND DIABETES
Authors: Madison Gunn, Iliana Lega, Andrea Pang, Peter Austin, Sheldon Singh, Paul Dorian, Cynthia Jackevicius, Karen Tu, Douglas Lee, Dennis Ko, Husam Abdel-Qadir
Journal: Journal of the American College of Cardiology (2021)
Modulating degradation of sodium alginate/bioglass hydrogel for improving tissue infiltration and promoting wound healing
Authors: Xin Zhang, Ying Li, Zhijie Ma, Dan He, Haiyan Li
Journal: Bioactive Materials (2021)

More and more studies have recognized that the nanosized pores of hydrogels are too small for cells to normally grow and newly formed tissue to infiltrate, which impedes tissue regeneration. Recently, hydrogels with macropores and/or controlled degradation attract more and more attention for solving this problem. Sodium alginate/Bioglass (SA/BG) hydrogel, which has been reported to be an injectable and bioactive hydrogel, is also limited to be used as tissue engineering scaffolds due to its nanosized pores. Therefore, in this study, degradation of SA/BG hydrogel was modulated by grafting deferoxamine (DFO) to SA. The functionalized grafted DFO-SA (G-DFO-SA) was used to form G-DFO-SA/BG injectable hydrogel. In vitro degradation experiments proved that, compared to SA/BG hydrogel, G-DFO-SA/BG hydrogel had a faster mass loss and structural disintegration. When the hydrogels were implanted subcutaneously, G-DFO-SA/BG hydrogel possessed a faster degradation and better tissue infiltration as compared to SA/BG hydrogel. In addition, in a rat full-thickness skin defect model, wound healing studies showed that, G-DFO-SA/BG hydrogel significantly accelerated wound healing process by inducing more blood vessels formation. Therefore, G-DFO-SA/BG hydrogel can promote tissue infiltration and stimulate angiogenesis formation, which suggesting a promising application potential in tissue regeneration.
ANKLE BRACHIAL INDEX IS A BETTER PREDICTOR OF CORONARY ARTERY DISEASE THAN PULSE WAVE VELOCITY IN A CARIBBEAN COHORT
Authors: Kenechukwu Mezue, Ahmed Goha, Safiya Weekes, Obiora Egbuche, Ahmed Hegazy, Dainia Baugh, Ernest Madu
Journal: Journal of the American College of Cardiology (2021)
30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS
Authors: Torsten Vahl, Raj Makkar, Susheel Kodali, Stephan Baldus, Hendrik Treede, David Daniels, Omar Khalique, Jörg Kempfert, Ron Waksman, James McCabe, Nicolas M. Van Mieghem, Adam Greenbaum, Won-Keun Kim, Tanja Rudolph, Thomas Walther, Stanley Chetcuti, Mark Russo, Lenard Conradi, Nadira Hamid, Martin Leon, Vinod Thourani
Journal: Journal of the American College of Cardiology (2021)
FULL PERCUTANEOUS ANGIO-GUIDED IMPLANTATION AND EXPLANTATION OF VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION USING PRE-CLOSING IN PATIENTS WITH REFRACTORY CARDIOGENIC SHOCK OR CARDIAC ARREST
Authors: Romain Gallet, Anne-Sophie Martin-Tuffreau, Francois Bagate, Madjid Boukantar, Andrea Mangiameli, Gabriel Saiydoun, Thierry Folliguet, Emmanuel Teiger
Journal: Journal of the American College of Cardiology (2021)
IMPACT OF TICAGRELOR MONOTHERAPY AFTER 3-MONTH DUAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME BY HIGH BLEEDING RISK: A POST HOC ANALYSIS OF THE RANDOMIZED TICO TRIAL
Authors: Yong-Joon Lee, Yongsung Suh, Jung-Sun Kim, Yun-Hyeong Cho, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Journal: Journal of the American College of Cardiology (2021)
Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease
Authors: Kelly A. Zalocusky, Ramsey Najm, Alice L. Taubes, Yanxia Hao, Seo Yeon Yoon, Nicole Koutsodendris, Maxine R. Nelson, Antara Rao, David A. Bennett, Jason Bant, Dah-eun J. Amornkul, Qin Xu, Alice An, Olga Cisne-Thomson, Yadong Huang
Journal: Nature Neuroscience (2021)
PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE
Authors: Lauren Sharan Ranard, Elena Donald, Shmuel Chen, Omar Khalique, Nadira Hamid, Rebecca Hahn, Ziad Ali, Vivian Ng, Jessica Forman, Erin Flattery, Hussein Rahim, Thomas Cahill, Anjali Sharma, Yaser Nemshah, Martin Leon, Robert Sommer, Torsten Vahl
Journal: Journal of the American College of Cardiology (2021)